Navigation Links
Endometrial Ablation Offers Relief for Abnormally Heavy or Irregular Menstrual Bleeding
Date:9/21/2009

In the US, one in five women suffer from heavy periods or irregular bleeding. Not only does this condition lead to discomfort and embarrassment, it also negatively impacts daily routines. Irregular menstrual bleeding is called menorrhagia. Most women with menorrhagia don't know that heavy bleeding is not normal--it is a recognized medical condition for which they can seek treatment.

Phoenix, AZ (Vocus/PRWEB) September 20, 2009. In the US, one in five women suffer from heavy periods or irregular bleeding. Not only does this condition lead to discomfort and embarrassment, it also negatively impacts daily routines. Irregular menstrual bleeding is called menorrhagia. Most women with menorrhagia don't know that heavy bleeding is not normal--it is a recognized medical condition for which they can seek treatment.

Many women are embarrassed to seek medical attention for their heavy periods, believing that bleeding heavily for 4 to 5 days or changing their pad every hour is something they have to live with. Some women worry that their treatment options may be extreme or invasive. However, more options exist now that ever before for women suffering from abnormally heavy bleeding.

The most common treatment options include endometrial ablation, hormones, dilation and curettage (D&C), and hysterectomy. While a physician will recommend the proper treatment for the specific needs of the patient, studies have shown that hormones are minimally effective. Another option, D&C, can minimize symptoms, but the results are not long-term. Lastly, hysterectomy is a major surgery with significant risks and recovery time.

Endometrial ablation has emerged as an attractive alternative for the treatment of menorrhagia. This procedure treats the lining of the uterus to control or stop bleeding. It does not involve removal of the uterus and it does not affect a woman's hormone levels.

During the procedure a lighted viewing instrument (hysteroscope) and other instruments are used to destroy (ablate) the uterine lining, or endometrium.

Because endometrial ablation destroys a thin layer of the lining of the uterus, menstrual flow stops in many women. In some women, menstrual bleeding is only reduced to normal or lighter levels. If ablation does not control heavy bleeding, further treatment or surgery may be required.

The most common methods of ablation are thermal (by laser, radiofrequency, or heated saline,) Electricity (using a special scope and a loop or roller-ball electrode,) freezing or microwave.

Endometrial ablation is usually done in an outpatient facility or hospital and, depending on the method of ablation, usually takes only a short time to complete. The procedure may be done using a local or spinal anesthesia.

DoctorFinders.com helps to disseminate information regarding the treatments for menorraghia, including endometrial ablation, through its growing website. Thousands are logging on to not only learn of the latest advancements in the medical field, but to also find a physician or surgeon who is right for them.

Contact: Riley Horlacher
Company: DoctorFinders.com
Website: www.doctorfinders.com
Phone: (877) 619-7159

# # #

Read the full story at http://www.prweb.com/releases/womens_health/endometrial_ablation/prweb2917094.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Internal radiotherapy better than external for quality of life in endometrial cancer patients
2. Global view shows link between endometrial cancer and vitamin D status
3. Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist
4. Two Endometrial Cancer Treatments May Not Work
5. Ovary Removal May Not Be Needed in Endometrial Cancer
6. Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause
7. Gene Mutation May Up Risks of Endometrial Cancer
8. Dream team targets key driver for breast, ovarian, endometrial cancers
9. New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy
10. Obesity Greatly Raises Endometrial Cancer Risk
11. New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... NY & Salt Lake City, UT (PRWEB) , ... February 05, ... ... Founder of Activz Whole-Food Nutrition , announced that the much-anticipated feature with author ... the New Really Cool Humans Amateur TV Network. , Each week, on his weekly ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... addition of micro-needling services in their Napa Valley office. The technique utilizes the ... Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a select ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to once again host, Swirl, A Wine Tasting Event at the La Gorce ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: